In a potential landmark development in the early detection and prevention of Alzheimer’s disease, a Brown University research team on Monday tested the first person enrolled in a study of whether a drug being developed for prevention of the fatal disease can lower deposits in the eye of the same plaque that forms in the brains of Alzheimer’s patients.
“…yet another weapon in the war against Alzheimer’s.”
–Dr. Stephen Salloway, head of Butler’s Memory and Aging Program
With today’s technology, plaque deposits can be detected before an individual shows symptoms of Alzheimer’s. Preventing or reversing their formation can stop cognitive decline.
For the full story, visit the Providence Journal